Georg C. Hutterer obtained his MD in 2001 at the Karl-Franzens Universität Graz, Austria. He completed a one-year post-doctoral research fellowship at the Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center (CHUM), Montreal, QC, Canada, under supervision of Prof. Pierre I. Karakiewicz, MD, FRCSC, where he published numerous peer-reviewed papers about different aspects of renal cell carcinoma including novel prognostic factors and models. Prof. Hutterer is an experienced Urologist with special focus on the treatment of advanced renal cell-, urothelial-, and prostate cancer patients. He received several research awards and grants, published over 100 peer-review papers to date and currently is the 2. Deputy Chairman of the Department of Urology of the Medical University of Graz.
Prof. Thomas Powles and GU CONNECT expert, Assoc. Prof. Georg Hutterer discuss the role of VEGFR-TKIs in the treatment of advanced renal cell carcinoma (RCC) alone or in combination with immunotherapy.